“…The ChAdOx1-nCoV 19 is another adenovirus-based vaccine for which data on VITT have been published in the medical literature. There are data on 58 cases(45 females) of whom 48 were aged <60 [ [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] ]. The twin derangements of thrombocytopenia and raised D-dimer levels were documented in 51 cases.…”